Christoph Turck's Biography

Christoph Turck, Head, Max Planck Institute of Psychiatry

Born in Hamberg, Germany. PhD in chemistry, RWTH Aachen, Germany (1983). Postdoc, Roche Institute of Molecular Biology, Nutley, NJ, USA (1983-1986). Professor of Medicine, Director of Protein Structure Laboratory, University of California San Francisco, Howard Hughes Medical Institute (1986-2002). Since 2002, Research group leader, Proteomics and Biomarkers, MPI of Psychiatry.

From Proteomes to Pathways to Biosignatures – Progress Towards Understanding Psychiatric Disorder Etiology

Thursday, 10 May 2012 at 10:00

Add to Calendar ▼2012-05-10 10:00:002012-05-10 11:00:00Europe/LondonFrom Proteomes to Pathways to Biosignatures – Progress Towards Understanding Psychiatric Disorder Etiology SELECTBIOenquiries@selectbiosciences.com

Proteomic technologies in combination with pathway analysis promise to be of great value in molecular medicine, particularly for the discovery and validation of disease markers. Our biomarker detection efforts range from classical proteomics approaches such as quantitative mass spectrometry of brain tissue and body fluid proteins to in silico analyses of public data. A particular focus is the use of animal models that represent selected endophenotypes characteristic for the respective clinical psychiatric phenotype in humans. A comprehensive and sensitive proteomics platform that is based on metabolic labeling of mouse models with stable isotopes is used for mass spectrometry based analyses of protein levels and turnover. The resulting data can be used to detect disease relevant pathways and identify biosignatures that can be translated into the clinic.

Add to Calendar ▼2012-05-10 00:00:002012-05-11 00:00:00Europe/LondonDisease BiomarkersSELECTBIOenquiries@selectbiosciences.com

Conference Sponsors